Victory Capital Management’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.52M Buy
261,531
+10,200
+4% +$293K ﹤0.01% 1193
2025
Q1
$8.43M Sell
251,331
-30,120
-11% -$1.01M 0.01% 1115
2024
Q4
$14.4M Sell
281,451
-61,893
-18% -$3.16M 0.01% 955
2024
Q3
$17.5M Buy
343,344
+116,657
+51% +$5.96M 0.02% 895
2024
Q2
$10.2M Sell
226,687
-30,458
-12% -$1.36M 0.01% 1073
2024
Q1
$12M Buy
257,145
+73,038
+40% +$3.42M 0.01% 1006
2023
Q4
$6.55M Buy
184,107
+139,117
+309% +$4.95M 0.01% 1187
2023
Q3
$1.34M Buy
+44,990
New +$1.34M ﹤0.01% 1519
2023
Q1
Sell
-66,428
Closed -$1.22M 2612
2022
Q4
$1.22M Sell
66,428
-32,640
-33% -$597K ﹤0.01% 1632
2022
Q3
$1.95M Sell
99,068
-11,210
-10% -$220K ﹤0.01% 1462
2022
Q2
$2.06M Hold
110,278
﹤0.01% 1447
2022
Q1
$2.42M Sell
110,278
-4,490
-4% -$98.6K ﹤0.01% 1439
2021
Q4
$3.26M Sell
114,768
-80,670
-41% -$2.29M ﹤0.01% 1417
2021
Q3
$4.11M Buy
195,438
+115,820
+145% +$2.44M ﹤0.01% 1381
2021
Q2
$1.5M Sell
79,618
-3,540
-4% -$66.7K ﹤0.01% 1720
2021
Q1
$1.27M Buy
83,158
+30,720
+59% +$470K ﹤0.01% 1802
2020
Q4
$740K Sell
52,438
-9,240
-15% -$130K ﹤0.01% 1906
2020
Q3
$966K Sell
61,678
-2,080
-3% -$32.6K ﹤0.01% 1718
2020
Q2
$1.12M Sell
63,758
-305,690
-83% -$5.36M ﹤0.01% 1680
2020
Q1
$5.43M Buy
369,448
+174,210
+89% +$2.56M ﹤0.01% 1250
2019
Q4
$4.9M Sell
195,238
-19,130
-9% -$480K 0.01% 1193
2019
Q3
$3.22M Buy
214,368
+144,698
+208% +$2.18M ﹤0.01% 1301
2019
Q2
$1.74M Buy
69,670
+16,300
+31% +$408K ﹤0.01% 1176
2019
Q1
$1.22M Sell
53,370
-590
-1% -$13.4K ﹤0.01% 1210
2018
Q4
$1.62M Sell
53,960
-40,850
-43% -$1.22M ﹤0.01% 1093
2018
Q3
$2.72M Buy
+94,810
New +$2.72M 0.01% 1036